Inventor
LAMYA SHIHABUDDIN
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C12NMicroorganisms or enzymes26%
C07KPeptides13%
C07HSugars9%
PatentTitleYear
12,350,311Gene therapy for neurodegenerative disorders202512,297,431Modulation of huntingtin expression202511,975,043Gene therapy for neurodegenerative disorders202411,911,440Gene therapy for neurodegenerative disorders202411,554,161Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders202311,421,231Modulation of Huntington expression2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to IONIS PHARMACEUTICALS INC (2)· patent assignee history
2022–2025Based in US· patent location history
2023–2025Patents assigned to GENZYME CORP (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GENZYME CORP | 4 | 2023–2025 |
| IONIS PHARMACEUTICALS INC | 2 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2022–2025 |